GleanMark

ALDAMA PHARMACEUTICALS Trademark

ALDAMA PHARMACEUTICALS is a USPTO trademark filed by Aldama Pharmaceuticals, Inc.. Status: Pending.

Trademark Facts

MarkALDAMA PHARMACEUTICALS
Serial Number99266049
StatusPending
Filing Date2025-07-03
Mark TypeCombined
Nice Classes005 (Pharmaceuticals)
OwnerAldama Pharmaceuticals, Inc.
Attorney of RecordEric T. Fingerhut
Prosecution Events32
Latest EventAMPB on 2026-05-04

Goods & Services

Class 005: Dietary supplements; Pharmaceutical preparations for the treatment of a wide variety of diseases, conditions and disorders, namely, infectious diseases, cardiovascular diseases, respiratory diseases, gastrointestinal diseases, metabolic and endocrine disorders, neurological diseases and disorders, psychiatric and mental health disorders, namely, anxiety disorder, depression disorder, substance use disorder, post-traumatic stress disorder, and bipolar disorder, autoimmune and inflammatory diseases, musculoskeletal disorders, dermatological diseases, oncological diseases, hematological disorders, renal and urological diseases, hepatic diseases, ophthalmic diseases, otic diseases, allergic diseases, immunological disorders, pain and pain related conditions, namely, chronic low back pain, osteoarthritis, migraine and chronic headache disorders, fibromyalgia, and neuropathic pain, sleep disorders, reproductive and sexual health disorders, hormonal disorders, nutritional deficiencies, genetic disorders, namely, down syndrome, Klinefelter syndrome, cystic fibrosis, sickle cell disease and Marfan syndrome, and chronic and acute medical conditions, namely, hypertension, type 2 diabetes, asthma, acute myocardial infarction, and pneumonia; Class 040: Custom manufacture of pharmaceuticals

Recent Prosecution Activity

DateDocumentType
2026-04-28DrawingDRW
2026-04-28Preliminary AmendmentPRA
2026-04-24Amendment and Mail Process CompleteAMC
2026-04-24Final ActionFREF
2026-04-24Public NotePNR
2026-04-24Examiner's AmendmentEXAMA

USPTO Refusals on Record

Related